Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 304-990-8 | CAS number: 94313-91-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The substance and/or a structural analogue is irritating to skin and severely irritating to eyes.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vivo
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Remarks:
- in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Recently conducted guideline study to GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Human Skin Model Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion)
- GLP compliance:
- yes (incl. QA statement)
- Species:
- other: reconstructed human epidermis
- Strain:
- not specified
- Details on test animals or test system and environmental conditions:
- The purpose of this test is to evaluate the corrosivity potential of the test item using the EPISKIN™ in vitro Reconstructed Human Epidermis (RHE) Model. The EPISKIN™ model is able to distinguish between corrosive and non-corrosive chemicals for all of the chemical types studied, and is also able to distinguish between known R35 (UN packing group I) and R34 (UN packing group II & III) test items.
- Type of coverage:
- open
- Preparation of test site:
- other: none: reconstructed human epidermis
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- 50 µL
- Duration of treatment / exposure:
- 3, 60 and 240 minutes
- Details on study design:
- The procedure followed is based on the recommended EpiSkin™ Skin Corrosivity Test protocol INVITTOX N° 118(5) The test item is applied topically to the stratum corneum surface, at the air interface, so that undiluted and/or end use dilutions can be tested
directly. The test is based on the experience that corrosive chemicals are cytotoxic after a short term exposure to the EPISKIN™ model. Corrosive chemicals are able to penetrate the stratum corneum and are sufficiently cytotoxic to cause cell death in the underlying cell layers. Toxicity is determined by the metabolic conversion of the vital dye MTT to formazan by viable cells in the test item treated cultures relative to the negative control. - Irritation / corrosion parameter:
- other: percentage relative viability
- Run / experiment:
- 240 minutes
- Value:
- ca. 106.7
- Remarks on result:
- other: MTT reduction in the test item treated issues relative to negative control tissues
- Irritation / corrosion parameter:
- other: percentage relative viability
- Run / experiment:
- 60 minutes
- Value:
- ca. 125.5
- Remarks on result:
- other: MTT reduction in the test item treated tissues relative to negative control tissues
- Irritation / corrosion parameter:
- other: percentage relative viability
- Run / experiment:
- 3 minutes
- Value:
- ca. 132.7
- Remarks on result:
- other: MTT reduction in the test item treated tissues relative to negative control tissues
- Interpretation of results:
- other: not corrosive
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The substance was non-corrosive to the skin.
- Executive summary:
The corrosivity potential of CAS# 10595 -49 -0 was evaluated using the EPISKIN™ in vitro Reconstructed Human Epidermis (RHE) Model after treatment periods of 3, 60 and 240 minutes. This method was designed to be compatible with OECD Guideline 431 and Method 8.40 of (EC) No. 440/2008.
At the end of the exposure period the test item was rinsed from each tissue before each tissue was taken for MTT-Ioading. After MTT loading a total biopsy of each epidermis was made and placed into micro tubes containing acidified isopropanol for extraction of formazan crystals out of the MTT-loaded tissues.
At the end of the formazan extraction period each tube was mixed thoroughly and duplicate 200 µL samples were transferred to the appropriate wells of a pre-labelled 96-well plate. The optical density (OD) was measured at 540 nm (OD540).
Data are presented in the form of percentage viability (MTT reduction in the test item treated tissues relative to negative control tissues).
Results: The relative mean viability of the test item treated tissues was:
240 minutes exposure: 106.7 %
60 minutes exposure: 125.5 %
3 minutes exposure: 132.7 %
Quality criteria: The quality criteria required for acceptance of results in the test were satisfied.
Conclusion: The test item was considered to be Non-Corrosive to the skin.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Recently conducted guideline study to GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- GLP compliance:
- yes
- Species:
- other: EPISKIN reconstructed human epidermis
- Strain:
- not specified
- Details on test animals or test system and environmental conditions:
- The EPISKIN model is a three-dimensional reconstructed human epidermis model consisting of adult human-derived epidermal keratinocytes seeded on a dermal substitute consisting of a collagen type I matrix coated with type IV collagen. A highly differentiated and stratified epidermis model is obtained after a 13-Day culture period comprising of the main basal, supra basal, spinous and granular layers and a functional stratum corneum.
EPISKINTM MODEL KIT
Supplier : SkinEthic Laboratories, Nice, France
Date received : 05 June 2012 - Type of coverage:
- open
- Preparation of test site:
- other: none: reconstructed human epidermis
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- As supplied: 40% solution in water
- Duration of treatment / exposure:
- 15 minutes
- Observation period:
- 42 hours
- Number of animals:
- triplicate tissues were treated with the test item
- Details on study design:
- The principle of the assay is based on the measurement of cytotoxicity in reconstructed human epidermal cultures following topical exposure to the test item by means of the colourimetric MTT reduction assay. Cell viability is measured by enzymatic reduction of the yellow MTT tetrazolium salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) to a blue formazan salt (within the mitochondria of viable cells) in the test item treatedtissues relative to the negative controls. The concentration of the inflammatory mediator IL-1α in the culture medium retained following the 42-Hour post-exposure incubation period is also determined for test items which are found to be borderline non-irritant based upon the MTT reduction endpoint. This complimentary end-point will be used to either confirm a non-irritant result or will be used to override the non-irritant result.
- Irritation / corrosion parameter:
- other: other: percentage mean viability
- Value:
- 40.3
- Remarks on result:
- other:
- Remarks:
- Basis: mean. Time point: 15 min. Remarks: MTT reduction in the test item treated tissues relative to negative control tissues.
- Interpretation of results:
- irritating
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The substance was irritating to skin in an in vitro assay.
Referenceopen allclose all
Table 1 - Mean 0D540 Values and Viabilities for the Negative Control Item, Positive Control Item and Test Item
Item | Exposure Period | Mean OD540 of duplicate tissues | Relative mean viability (%) |
Negative Control Item | 240 minutes | 0.208 | 100* |
Positive Control Item | 240 minutes | 0.037 | 17.8 |
Test Item | 240 minutes | 0.222 | 106.7 |
60 minutes | 0.261 | 125.5 | |
3 minutes | 0.276 | 132.7 | |
* The mean viability of the negative control tissues is set at 100% |
The MTT solution containing the test item did not turn blue which indicated that the test item did not directly reduce MTT.
Mean OD540 Values and Percentage Viabilities for the Negative Control Item, Positive Control Item and Test Item | ||||||
Item | OD540 oftissues | Mean OD540of triplicatetissues | ± SD ofOD540 | Relativeindividualtissueviability (%) | Relativemeanviability (%) | ± SD ofRelativemeanviability (%) |
Negative Control Item | 0.733 | 0.856 | 0.107 | 85.6 | 100* | 12.5 |
0.928 | 108.4 | |||||
0.906 | 105.8 | |||||
Positive Control Item | 0.032 | 0.036 | 0.005 | 3.7 | 4.2 | 0.6 |
0.036 | 4.2 | |||||
0.041 | 4.8 | |||||
Test Item | 0.326 | 0.345 | 0.030 | 38.1 | 40.3 | 3.5 |
0.329 | 38.4 | |||||
0.379 | 44.3 |
SD = Standard deviation
* = The mean viability of the negative control tissues is set at 100%
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- an in vitro eye irritation study does not need to be conducted because adequate data from an in vivo eye irritation study are available
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1982
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to the guideline study with acceptable restrictions.
- Qualifier:
- according to guideline
- Guideline:
- other: USA Interagency Regulatory Liaison Group (IRLG, January 1981)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- GLP compliance:
- not specified
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: H. Fortkamp, 4540 Lengerich, Germany
- Weight at study initiation: 2.20 - 2.35 kg
- Age: 11-17 weeks
- Housing: single caging, metal cages
- Diet: ad libitum, Rabbit Diet, Ssniff Versuchstier Diäten GmbH, 4770 Soest/Westfalen, Germany
- Water: ad libitum
- Acclimation period: 20 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-23
- Humidity (%): 40-70
- Air changes (per hr): 10 per hour
- Photoperiod: 12 hours daily - Vehicle:
- unchanged (no vehicle)
- Controls:
- other: Each animal served as its one control. The test article was introduced into the conjunctival sac of one eye, the untreated eye serving as a control
- Amount / concentration applied:
- 0.1 ml of the test material was instilled into the conjunctival sac of the left eye while the right eye served as control.
- Duration of treatment / exposure:
- not rinsed
- Observation period (in vivo):
- Readings of ocular reactions were made 1-2 h, 24 h, 48 h, 72 h, 4 days, 7 days after treatment.
- Number of animals or in vitro replicates:
- 6
- Details on study design:
- PREPARATION OF ANIMALS
- 24 h before treatment eyes were examined for corneal lesions after application of one drop of fluorescein-sodium solution (2%)
APPLICATION OF TEST SUBSTANCE
- 0.1 mL test substance was instilled into the conjunctival sac of the left eye. The lids were then held together for 1-2 seconds. The untreated right eye served as control. Because one of test animals showed a moderate pain reaction (score 3; see table 1), all remaining rabbits received a local anaesthetic in both eyes shortly before the application of the test substance.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): the treated eye was not rinsed after treatment
SCORING SYSTEM (modified Draize system): the ocular reactions were assessed using the following numerical scoring system (see table 2) - Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Remarks:
- #1, #3, #5, #6
- Time point:
- other: 24 h, 48 h, 72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- not reversible
- Remarks:
- within 7 days
- Remarks on result:
- other: Pannus
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Remarks:
- #2, #4
- Time point:
- other: 24 h, 48 h, 72 h
- Score:
- 0
- Max. score:
- 4
- Reversibility:
- other: delayed opacity formation after 7 days
- Remarks on result:
- other: Pannus
- Irritation parameter:
- iris score
- Basis:
- mean
- Remarks:
- #1, #2, #3, #4, #5, #6
- Time point:
- other: 24 h, 48 h, 72 h
- Score:
- 1
- Max. score:
- 2
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Remarks:
- #2, #3, #4, #5, #6
- Time point:
- other: 24 h, 48 h, 72 h
- Score:
- 2
- Max. score:
- 3
- Reversibility:
- not fully reversible within: 7 days
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Remarks:
- #1
- Time point:
- other: 24 h, 48 h, 72 h
- Score:
- 2
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Remarks:
- #1, #2, #3, #4, #5, #6
- Time point:
- other: 24 h, 48 h, 72 h
- Score:
- 2
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 7 days
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Remarks:
- #1
- Time point:
- other: 24 h, 48 h, 72 h
- Score:
- 2
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritant / corrosive response data:
- The most remarkable reaction to the instillation of the test substance was a not discernible iris through cornea opacity in one animal on day 7 after the application. The investigation of the remaining animals showed Pannus formations also on day 7 after the application. As the post exposure observation period was less then 21 days reversibility of effects could not be determined.
- Other effects:
- no data
- Interpretation of results:
- Category 1 (irreversible effects on the eye)
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The test material caused serious damage to eyes in this study
- Executive summary:
A primary eye irritation study, performed according to the test plan P 4/152, 3-rd revision, refers to the recommended guidelines of the USA Interagency Regulatory Liaison Group (IRLG, January, 1981). Study performance is comparable to the guideline study.
0.1 ml of the substance (48 % a.i) undiluted were instilled into the conjunctival sac of one eye of 6 young female adult New Zealand White rabbits. Eyes were not washed. Animals then were observed for 7 days. Irritation was scored by the method of Draize.
Calculated mean scores following grading at 24, 48 and 72 hours after installation of the test material for effects on the cornea opacity are 1 for 4 of 6 animals and 0 for 2 of 6 animals. Mean scores for effects on the conjunctiva (redness) and chemosis were 2 for all animals; the effects decreased in 3 of 6 animals were reversible in one animal within 7 days. Mean scores for effects on the iris were 1 for all animals and were fully reversible within 7 days.
As the most remarkable reaction to the instillation of the test substance was cornea opacity (score 4) in one of 6 animals and pannus in all animals at day 7 after application. As the post exposure observation period was less then 21 days reversibility of effects could not be determined.
In this study, the substance (48 % a.i) induced serious damage to eyes.
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted prior to OECD guideline and GLP. It is only reported in very limited detail.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- yes
- Remarks:
- Only 10 mg was instilled into the eye
- GLP compliance:
- no
- Species:
- rabbit
- Strain:
- other: Albino
- Vehicle:
- unchanged (no vehicle)
- Controls:
- no
- Amount / concentration applied:
- 10 mg
- Duration of treatment / exposure:
- Not applicable
- Observation period (in vivo):
- 7 days
- Number of animals or in vitro replicates:
- 5 males
- Remarks on result:
- other: The eye scores were not reported in the study report.
- Irritant / corrosive response data:
- The eye scores were not reported in the study report.
- Other effects:
- The substance produced moderate to severe conjunctivitis and chemosis within 24 hours in all animals. Mild corneal opacity and severe pannus developed at 1 week in 3/5 animals. Mild iritis appeared at 4 hours in 3/5 animals however gradually dissapeared during the week.
- Interpretation of results:
- irritating
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The substance gave rise to significant irritatation to the rabbit eye after dosing of 10mg.
Referenceopen allclose all
Table 3: Irritant/corrosive response for each animal at each observation time
Score at time point / Reversibility |
Cornea opacity |
Cornea area |
Iris |
Conjunctivae Redness |
Conjunctivae Chemosis |
Conjunctivae discharge |
Max. score: 4 |
Max. score: 4 |
Max. score: 2 |
Max. score: 3 |
Max. score: 4 |
Max. score: 3 |
|
1-2 hours |
1/0/1/0/1/1 |
2/0/2/0/2/2 |
1/1/1/1/1/1 |
2/2/2/2/2/2 |
2/2/2/2/2/2 |
1/1/1/1/1/1 |
1 day |
1/0/1/0/1/1 |
2/0/2/0/2/2 |
1/1/1/1/1/1 |
2/2/2/2/2/2 |
2/2/2/2/2/2 |
2/2/2/2/2/2 |
2 days |
1/0/1/0/1/1 |
2/0/2/0/2/2 |
1/1/1/1/1/1 |
2/2/2/2/2/2 |
2/2/2/2/2/2 |
2/2/2/2/2/2 |
3 days |
1/0/1/0/1/1 |
2/0/2/0/2/2 |
1/1/1/1/1/1 |
2/2/2/2/2/2 |
2/2/2/2/2/2 |
2/2/2/2/2/2 |
4 days |
1/0/1/0/1/1 |
2/0/2/0/2/2 |
1/1/1/1/1/1 |
1/2/2/1/2/2 |
1/2/2/1/2/2 |
1/2/2/1/2/2 |
7 days |
1/2/2/1/3/4 |
4P/4P/4P/4P/4P/4P |
0/0/0/0/0/* |
0/1/1/1/2/2 |
0/1/1/1/2/2 |
0/1/1/0/1/2 |
Average 24h, 48h, 72h |
1/0/1/0/1/1 |
2/0/2/0/2/2 |
1/1/1/1/1/1 |
2/2/2/2/2/2 |
2/2/2/2/2/2 |
2/2/2/2/2/2 |
Reversibility |
n./n./n./n./n./n. |
n./n./n./n./n./n. |
c./c./c./c./c./* |
c./n.c./n.c./n.c./n./n. |
c./n.c./n.c./n.c./n./n. |
c./n.c./n.c./c./n.c./n. |
P = Pannus,
* Evaluation is not possible because of corneal opacity
c. = completely reversible
n.c. = not completely reversible
n.= not reversible
Reactions observed at 2 hours reading after the application
- Clear redness and chemosis of the conjunctiva (score 2)
- Light ocular secretion production (score 1)
- Isolated small diffuse areas in more as a quarter of a cornea (score 1) observed in 4/6 rabbits.
Reactions observed within 1 – 7 days after the application
- Clear redness and chemosis of the conjunctiva (score 2), decreased in 4 animals by the end of the study.
- Moderate pericorneal Hyperaemia of iris (score 1), decreased within the 7 days after the treatment
- Isolated small diffuse areas in more as a quarter of a cornea (score 1) observed in 4/6 rabbits turned into the corneal opacity in all animals by the end of the study.
- Conjunctivae discharge with moistening of the lids and hairs just adjacent to the lids (score 2), decreased in 5/6 of the rabbits by the end of the study.
Table 4: Assessment of results (mean values)
Days after treatment |
Mean values |
|||
Conjunctivae (max. 20) |
Iris (max. 10) |
Cornea (max. 80) |
Mean total score (max. 110) |
|
0 (2 h) |
10 |
5 |
6.7 |
21.7 |
1 |
12 |
5 |
6.7 |
23.7 |
2 |
12 |
5 |
6.7 |
23.7 |
3 |
12 |
5 |
6.7 |
23.7 |
4 |
10 |
5 |
6.7 |
21.7 |
7 |
6.3 |
0* |
43.3 |
49.6 |
*Evaluation is not possible because of corneal opacity
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Based on two reliable in vitro studies, a structural analogue (3-(dodecanoylamino)-N,N,N-trimethylpropan-1-aminium methyl sulfate; 10595-49-0) has been shown to be irritating to skin but not corrosive. Given the in vitro positive response for skin irritation, there is no scientific justification for proceeding with an in vivo skin irritation study.
In a reliable in vivo eye irritation study the substance was tested as a 48% solution and gave a severe eye response. In a second unreliable study on a structurally related substance (3-(dodecanoylamino)-N,N,N-trimethylpropan-1-aminium methyl sulfate; 10595-49-0), dosing of only 10mg gave rise to significant irritation.
Justification for selection of skin irritation / corrosion
endpoint:
This is a Klimisch 1 study (or Klimisch 2 allowing for read-across)
which demonstrates skin irritation in vitro.
Justification for selection of eye irritation endpoint:
This study is Klimisch 2 whereas the other available study is
Klimisch 3.
Effects on skin irritation/corrosion: irritating
Effects on eye irritation: corrosive
Justification for classification or non-classification
Given the observed in vitro skin responses (irritant but not corrosive) the substance is classified as Skin irritant, Category 2.
Given the severe response observed in an in vivo eye irritation study, the substance will be classified as an Eye Irritant, Category 1.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.